AQR Capital Management
CLVS

AQR Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

AQR Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,685
Closed -$75K – 2303
2020
Q4 		$75K Buy
+15,685
New +$79.3K ﹤0.01% 2163
2018
Q4 		– Sell
-39,393
Closed -$1.16M – 2310
2018
Q3 		$1.16M Hold
39,393
– – ﹤0.01% 1651
2018
Q2 		$1.79M Sell
39,393
-2,960
-7% -$144K ﹤0.01% 1472
2018
Q1 		$2.24M Sell
42,353
-12,183
-22% -$711K ﹤0.01% 1307
2017
Q4 		$3.71M Sell
54,536
-9,814
-15% -$686K ﹤0.01% 1135
2017
Q3 		$5.3M Buy
64,350
+641
+1% +$50.8K 0.01% 995
2017
Q2 		$5.96M Buy
63,709
+6,727
+12% +$412K 0.01% 960
2017
Q1 		$3.63M Buy
+56,982
New +$3.46M ﹤0.01% 1143
2016
Q1 		– Sell
-17,345
Closed -$607K – 2307
2015
Q4 		$607K Buy
17,345
+10,425
+151% +$672K ﹤0.01% 1794
2015
Q3 		$636K Sell
6,920
-3,705
-35% -$321K ﹤0.01% 1632
2015
Q2 		$934K Buy
+10,625
New +$910K ﹤0.01% 1520
2014
Q3 		– Sell
-11,466
Closed -$475K – 2615
2014
Q2 		$475K Sell
11,466
-21,500
-65% -$1.11M ﹤0.01% 2012
2014
Q1 		$2.28M Buy
32,966
+5,800
+21% +$426K 0.01% 1224
2013
Q4 		$1.64M Buy
27,166
+529
+2% +$28.8K ﹤0.01% 1465
2013
Q3 		$1.62M Sell
26,637
-88,276
-77% -$6.26M 0.01% 1410
2013
Q2 		$7.7M Buy
+114,913
New +$5.17M 0.03% 670

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AQR Capital Management's CLVS Position: Q1 2021 in Review

AQR Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q1 2021, closing a stake of 15,685 shares — an estimated $75K sold.

AQR Capital Management first reported a position in CLVS in Q2 2013 and held it in 16 quarters. The position peaked at $7.7M in Q2 2013. 165 funds tracked by Wall St. Rank hold CLVS as of Q1 2021.

  • AQR Capital Management reported no remaining Clovis Oncology, Inc. position as of Q1 2021 after selling out during the quarter.
  • AQR Capital Management sold 15,685 Clovis Oncology, Inc. shares in Q1 2021, an estimated $75K.
  • AQR Capital Management first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 16 quarters.
  • AQR Capital Management's Clovis Oncology, Inc. position peaked at $7.7M in Q2 2013.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2021.

Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.